Gnipst Bulletin 23.2
-
Upload
gnipst-bulletin -
Category
Documents
-
view
228 -
download
0
Transcript of Gnipst Bulletin 23.2
-
7/29/2019 Gnipst Bulletin 23.2
1/14
1118-1177-4796-9849-7562-5062mail
GNIPST BULLETIN 2013
8th March 2013 Volume No.: 23 Issue No.: 02
ContentsMessage from GNIPS
Letter to the EditorNews Update
Disease Outbreak Ne
Health Awareness
Forth Coming Events
Drugs Update
Campus News
Students Section
Editors Note
Archive
Vision
TO GROW AS A CENTRE OF EXCELLENCE IN THE FIELD O
PHARMACEUTICAL AND BIOLOGICAL SCIENCE
EDITOR: Debabrata Ghosh DastidarGURU NANAK INSTITUTE OF PHARMACEUTICAL SCIENCE ANDTECHNOLOGY
GNIPST Photo Gallery
For your comments/contributionOR
For Back-Issues,
mailto:[email protected]
1
https://picasaweb.google.com/111714720327580099858/GNIPSTCricketTournament2013mailto:[email protected]:[email protected]:[email protected]://picasaweb.google.com/111714720327580099858/GNIPSTCricketTournament2013 -
7/29/2019 Gnipst Bulletin 23.2
2/14
08-03-2013
MESSAGE FROM GNIPSTAll the members of GNIPST are proud to publish the 23rd Volume
of GNIPST BULLETIN. This bulletin has successfully
completed its twenty months journey. We hope it has kept the
readers updated of recent activities in pharmaceutical & biological
sciences and also introduced them with the different activities of
our esteemed institution. We are thankful to all of you for your
great cooperation & support and are looking forward to the same in
future.
LETTER TO THE EDITOR.
NEWS UPDATE
Pour, Shake and Stir: How Gold Particles, DNAand Water Have the Potential to Shape the
Future of Medicine (28 FEBRUARY 2013)
A diagnostic "cocktail" containing a single drop of blood, a dribble
of water, and a dose of DNA powder with gold particles could
mean rapid diagnosis and treatment of the world's leading diseases
in the near future.Read moreUltrasound to Detect Lung Congestion in Dialysis
Patients May Help Save Lives (28 FEBRUARY 2013)
Click here to go at the top1
http://www.sciencedaily.com/releases/2013/02/130228171529.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/02/130228171529.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/02/130228171529.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/02/130228171529.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29 -
7/29/2019 Gnipst Bulletin 23.2
3/14
08-03-2013
Lung ultrasound can detect asymptomatic lung congestion in
dialysis patients and can predict their risk of dying prematurely or
experiencing heart attacks or other cardiac events. Treating
asymptomatic lung congestion may help improve cardiovascular
health and prevent cardiovascular deaths in dialysis patients. Lung
congestion is highly prevalent and often asymptomatic among
patients with kidney failure.Read more
Machine Similar to Dialysis Removes Cholesterol
from Blood? (28 FEBRUARY 2013)
A treatment that's similar to kidney dialysis is removing
cholesterol from the blood of patients who cannot control
cholesterol through diet, exercise and medications.Read more
Excess Dietary Salt May Drive the Development
of Autoimmune Diseases(06 MARCH 2013)
Increased dietary salt intake can induce a group of aggressive
immune cells that are involved in triggering and sustaining
autoimmune diseases. In autoimmune diseases, the immune
system attacks healthy tissue instead of fighting pathogens. Inautoimmune diseases, the immune system attacks healthy tissue
instead of fighting pathogens.Read more
Click here to go at the top2
http://www.sciencedaily.com/releases/2013/02/130228171454.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/02/130228171454.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/02/130228171454.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/02/130228171354.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/02/130228171354.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/02/130228171354.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/03/130306134358.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/03/130306134358.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/03/130306134358.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/03/130306134358.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/02/130228171354.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/02/130228171454.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29 -
7/29/2019 Gnipst Bulletin 23.2
4/14
08-03-2013
Nanoparticles Loaded With Bee Venom Kill HIV
(07 MARCH 2013)
Nanoparticles carrying a toxin found in bee venom can destroy
human immunodeficiency virus (HIV) while leaving surrounding
cells unharmed, researchers have shown. The finding is an
important step toward developing a vaginal gel that may prevent
the spread of HIV, the virus that causes AIDS.Read more
HEALTH AWARENESS
MISUSE AND OVERUSE OF INJECTION WORLDWIDE
Injection is one of the most common health care procedures.
Each year at least 16 billion injections are administered in
developing and transitional countries. The vast majority, around
95%, are given in curative care. Immunization accounts for
around 3% of all injections, with the remainder for other
indications, including use of injections for transfusion of blood
and blood products and contraceptives.
In certain regions of the world, use of injections has completely
overtaken the real need, reaching proportions no longer based on
rational medical practice. In some situations, as many as nine out
of ten patients presenting to a primary healthcare provider
Click here to go at the top3
http://www.sciencedaily.com/releases/2013/03/130307160325.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/03/130307160325.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/03/130307160325.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/03/130307160325.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29 -
7/29/2019 Gnipst Bulletin 23.2
5/14
08-03-2013
receive an injection, over 70% of which are unnecessary or could
be given in an oral formulation.
Patients tend to prefer injections because they believe them to be
stronger and faster medications. They also believe that doctors
regard injections to be the best treatment. In turn, doctors over-
prescribe injections because they believe that this best satisfies
patients, even though patients are often open to alternatives. In
addition, prescription of an injection sometimes allows thecharging of a higher fee for service. Better communication
between patients and providers can clarify these types of
misunderstandings and help to reduce injection overuse.
UNSAFE INJECTION PRACTICES: A PLAGUE OF MANYHEALTH SYSTEM S
A safe injection does no harm. However, when safety control
practices are not respected, severe infections can result, putting
human lives at risk.
Reuse of syringes and needles in the absence of sterilization
exposes millions of people to infections. Assessments carried out
in numerous countries have revealed that syringes and needles
are often just rinsed in a pot of tepid water between injections.
Click here to go at the top4
-
7/29/2019 Gnipst Bulletin 23.2
6/14
08-03-2013
Worldwide, up to 40% of injections are given with syringes and
needles reused without sterilization and in some countries this
proportion is as high as 70%.
Other unsafe practices, such as poor collection and disposal of
dirty injection equipment, expose healthcare workers and the
community to the risk of needle stick injuries. In some countries
unsafe disposal can lead to re-sale of used equipment on the
black market. The proportion of non-industrialized countriesstill reporting that they use open burning of syringes (considered
unacceptable by WHO) was 50% in 2004.
BURDEN OF DISEASE ASSOCIATED WITH UNSAFE
INJECTION PRACTICES
The most recent study* indicates that each year unsafe injections
cause an estimated 1.3 million early deaths, a loss of 26 million
years of life, and an annual burden of USD 535 million in direct
medical costs.
Unsafe injection practices are a powerful engine to transmit
blood-borne pathogens, including hepatitis B virus (HBV),
hepatitis C virus (HCV) and human immunodeficiency virus
(HIV). Because infection with these viruses initially presents no
Click here to go at the top5
-
7/29/2019 Gnipst Bulletin 23.2
7/14
08-03-2013
symptoms, it is a silent epidemic. However, the consequences of
this are increasingly recognized.
Hepatitis B virus: HBV is highly infectious and causes the
highest number of infections: in developing and transitional
countries 21.7 million people become infected each year,
representing 33% of new HBV infections worldwide
Hepatitis C virus: Unsafe injections are the most common
cause of HCV infection in developing and transitional countries,causing two million new infections each year and accounting for
42% of cases.
Human immunodeficiency virus: Globally nearly 2% of all new
HIV infections are caused by unsafe injections. In South Asia up
to 9% of new cases may be caused in this way. Such proportions
can no longer be ignored.
HBV, HCV, and HIV cause chronic infections that lead to
disease, disability and death a number of years after the unsafe
injection. Those infected with hepatitis B virus in childhood will
typically present with chronic liver disease by the age of 30 years,
at the prime of their life. This has a dramatic effect on national
economies.
Click here to go at the top6
-
7/29/2019 Gnipst Bulletin 23.2
8/14
08-03-2013
*The cost of unsafe injections by M.A. Miller & E. Pisani:
Bulletin of the World Health Organization, Vol. 77, no 10, 808-
811.
SAFE AND APPROPRIATE USE OF INJECTIONS IS WITHIN
OUR GRASP
Unsafe injection practices are often viewed as a chronic problem
with no easy solution. However, safe and appropriate use of
injections can be achieved by adopting a three part strategy:
(1) Changing behaviour of health care workers and patients
Twenty years into the HIV pandemic, knowledge of HIV among
patients and health care workers in some countries has driven
consumer demand for safe injection equipment and irreversibly
improved injection practices. With growing knowledge of HCV
and HBV, similar patterns of consumer demand for safe
injections should emerge. HIV prevention programmes can be
expanded to include injection safety components.
(2) Ensuring availability of equipment and supplies
Simply increasing the availability of safe injection equipment can
stimulate demand and improve practices. Because the cost of safe
Click here to go at the top7
-
7/29/2019 Gnipst Bulletin 23.2
9/14
08-03-2013
disposable syringes is low (less than 5 US cents per unit) when
compared to the fee paid for receiving an injection (50 US cents
on average), patients are usually willing to pay a little extra for
safety once they personalize the risks.
(3) Managing waste safely and appropriately
As waste disposal is frequently not an integral part of health
planning, unsafe waste management is common. However, whenit is appropriately planned, significant results ensue. National
health care waste management strategies require a national
policy to manage health care waste, a comprehensive system for
implementation, improved awareness and training of health
workers at all levels, as well as the selection of appropriate
options for the local solutions.
DISEASE OUTBREAK NEWS
FORTHCOMING EVENTS
AICTE sponsored National Seminar on Recent Advances in the development
of Natural Antioxidant
Click here to go at the top8
-
7/29/2019 Gnipst Bulletin 23.2
10/14
08-03-2013
Date: 12 March 2013 13 March 2013, Venue: Department of Food
Technology, Guru Nanak Institute of Technology, 157/F, Nilgunj Road,
Panihati, Kolkata-700 114Details.
DRUGS UPDATES
FDA approves Stivarga for advanced
gastrointestinal stromal tumors(25FEBRUARY 2013
)The U.S. FDA expanded the approved use of Stivarga (regorafenib)
to treat patients with advanced gastrointestinal stromal tumors
(GIST) that cannot be surgically removed and no longer respond
to other FDA-approved treatments for this disease. Read more
FDA approves Osphena for postmenopausalwomen experiencing pain during sex
(26 FEBRUARY 2013)
The U.S. FDA approved Osphena (ospemifene) to treat women
experiencing moderate to severe dyspareunia (pain during sexual
intercourse), a symptom of vulvar and vaginal atrophy due to
menopause. Read more
Click here to go at the top9
http://www.gnit.ac.in/index.phphttp://www.gnit.ac.in/index.phphttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm340958.htmhttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm340958.htmhttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm341128.htmhttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm341128.htmhttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm341128.htmhttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm340958.htmhttp://www.gnit.ac.in/index.php -
7/29/2019 Gnipst Bulletin 23.2
11/14
08-03-2013
CAMPUS NEWS
STUDENTS SECTION
WHO CAN ANSWER FIRST???() Which is the first patented organism in the
world?() August Dvorak and W. Dealy are associated
with invention of which computer device?Answer of Previous Issue Question:
A)Giraffe B)Butter
Send your thoughts/ Quiz/Puzzles/games/write-ups or any other contributions for Students Section& answers of this Section at [email protected]
EDITORS NOTE
I am very happy to publish the 22nd issue of 23rd Volume of GNIPST
BULLETIN. It is my great pleasure to introduce you to the newly
launched facebook account GNIPST bulletin. You are cordially
Click here to go at the top10
mailto:[email protected]:[email protected]:[email protected] -
7/29/2019 Gnipst Bulletin 23.2
12/14
08-03-2013
invited to add this account to your friend list. The current issues will
also be directly available on facebook.
I would like to convey my thanks to all the GNIPST members and
the readers for their valuable comments, encouragement& supports.
Special thanks to Dr. Prerona Saha for her advice; Mr. Soumya
Bhattacharya, for his contribution instudents section.
It would be my great pleasure to receive the contributions,
suggestions & feedback from your desk for further upliftment of this
deliberation GNIPST BULLETIN.
Click here to go at the top11
-
7/29/2019 Gnipst Bulletin 23.2
13/14
08-03-2013
ARCHIVE
The general body meeting of APTI, Bengal Branch has been
conducted at GNIPST on 15th June, 2012. The programme started
with a nice presentation by Dr. Pulok Kr. Mukherjee, School of
Natural Products, JU on the skill to write a good manuscript for
publication in impact journals. It was followed by nearly two hour
long discussion among more than thirty participants on different
aspects of pharmacy education. Five nonmember participants
applied for membership on that very day.
GNIPST is now approved by AICTE and affiliated to WBUT forconducting the two years post graduate course (M.Pharm) in
PHARMACOLOGY. The approved number of seat is 18.The number of seats in B.Pharm. has been increased from 60 to
120.
2nd World Congress on Ga-68 (Generators and Novel Radiopharmaceuticals),
Molecular Imaging (PET/CT), Targeted Radionuclide Therapy, and
Dosimetry (SWC-2013) : On the Way to Personalized Medicine
Click here to go at the top12
-
7/29/2019 Gnipst Bulletin 23.2
14/14
08-03-2013
Dates 28 Feb 2013 02 Mar 2013
Location: Chandigarh, India.Details. AICTE has sanctioned a release of grant under Research
Promotion Scheme (RPS) during the financial year 2012-
13to GNIPST as per the details below:
a. Beneficiary Institution: Guru Nanak Institution of
Pharmaceutical Science & Technology.
b. Principal Investigator: Dr. LopamudraDutta.
c. Grant-in-aid sanctioned:Rs. 16,25000/- only
d. Approved duration: 3 years
e. Title of the project: Screening and identification of
potential medicinal plant of Purulia&Bankuradistricts of West
Bengal with respect to diseases such as diabetes, rheumatism,
Jaundice, hypertension and developing biotechnological tools forenhancing bioactive molecules in these plant.
Click here to go at the top13
http://www.2ndworldcongress-ga-68.de/http://www.2ndworldcongress-ga-68.de/http://www.2ndworldcongress-ga-68.de/http://www.2ndworldcongress-ga-68.de/